0I1B.LSE Enovis Corporation

Healthcare Medical Devices London Exchange
- USD
Market cap
-
P/E
-
P/B
-
ROE
-1.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0I1B.LSE undervalued?

Graham number

The Graham number of Enovis Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Enovis Corporation fundamental analysis

No fundamental analysis for Enovis Corporation yet.

Enovis Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Enovis Corporation

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy …

Full company profile